AU2003299025A1 - Peptides inhibiting specific cleaving activities of presenilins - Google Patents

Peptides inhibiting specific cleaving activities of presenilins

Info

Publication number: AU2003299025A1
Authority: AU; Australia
Prior art keywords: presenilins; inhibiting specific; specific cleaving; peptides inhibiting; cleaving activities
Prior art date: 2002-09-17
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003299025A

Other languages

English (en)

Inventor

Wim Annaert

Bart De Strooper

Johannes Petrus Maria Langedijk

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Katholieke Universiteit Leuven

Pepscan Systems BV

Original Assignee

Vlaams Instituut voor Biotechnologie VIB

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-09-17

Filing date

2003-09-17

Publication date

2004-04-08

2003-09-17 Application filed by Vlaams Instituut voor Biotechnologie VIB filed Critical Vlaams Instituut voor Biotechnologie VIB

2004-04-08 Publication of AU2003299025A1 publication Critical patent/AU2003299025A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Zoology (AREA)
Neurosurgery (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Hospice & Palliative Care (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Marine Sciences & Fisheries (AREA)
Toxicology (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

AU2003299025A 2002-09-17 2003-09-17 Peptides inhibiting specific cleaving activities of presenilins Abandoned AU2003299025A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP02078915		2002-09-17
EP02078915.2		2002-09-17
PCT/EP2003/050631 WO2004026331A1 (fr)	2002-09-17	2003-09-17	Peptides inhibant les activites de clivage specifiques des presenilines

Publications (1)

Publication Number	Publication Date
AU2003299025A1 true AU2003299025A1 (en)	2004-04-08

Family

ID=32011008

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003299025A Abandoned AU2003299025A1 (en)	2002-09-17	2003-09-17	Peptides inhibiting specific cleaving activities of presenilins

Country Status (2)

Country	Link
AU (1)	AU2003299025A1 (fr)
WO (1)	WO2004026331A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2006005587A1 (fr) *	2004-07-12	2006-01-19	Geneprot, Inc.	Espece de polypeptides utilisee pour le traitement de troubles neurologiques
WO2006005592A1 (fr) *	2004-07-12	2006-01-19	Geneprot Inc.	Espece de polypeptides utiles pour le traitement de troubles neurologiques
WO2006029852A1 (fr) *	2004-09-14	2006-03-23	Geneprot Inc.	Espece de polypeptide utilisee dans le traitement des affections neurologiques

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1998003643A2 (fr) *	1996-07-22	1998-01-29	Smithkline Beecham Pharma Gmbh	Animaux transgenic avec sequences app ou a4ct mutantes humaines
EP1012277B1 (fr) *	1997-04-25	2008-07-16	Vlaams Interuniversitair Instituut voor Biotechnologie vzw.	Proteines interagissant avec syndecane et utilisation de celles-ci
GB0008710D0 (en) *	2000-04-07	2000-05-31	Merck Sharp & Dohme	Therapeutic compounds
DE10032709A1 (de) *	2000-07-07	2002-01-24	Boehringer Ingelheim Pharma	Aspartyl-Protease
WO2002074804A2 (fr) *	2001-03-16	2002-09-26	Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw	Domaines de liaison entre des presenilines et leurs substrats utilises comme cibles pour le criblage de medicaments

2003
- 2003-09-17 AU AU2003299025A patent/AU2003299025A1/en not_active Abandoned
- 2003-09-17 WO PCT/EP2003/050631 patent/WO2004026331A1/fr not_active Ceased

Also Published As

Publication number	Publication date
WO2004026331A8 (fr)	2004-07-22
WO2004026331A1 (fr)	2004-04-01

Publication	Publication Date	Title
AU2003265235A1 (en)	2003-12-19	Non-affinity purification of proteins
AU2003264939A1 (en)	2004-04-19	Watch
AU2003301451A1 (en)	2004-05-04	Component capable of being cooled
AU2003243926A1 (en)	2004-01-19	Stabilization of granules
AU2002238814A1 (en)	2003-07-30	Provision of location information
AU2003222197A1 (en)	2003-09-02	Inhibition of rna function
AU2003265430A1 (en)	2004-03-29	Ant spray containing d-limonene
AU2003269984A1 (en)	2004-03-11	Protease inhibitors
AU2003295427A1 (en)	2004-06-03	Flaviviris fusion inhibitors
AU2003252593A1 (en)	2004-02-02	Sulfotransferase inhibitors
AU2003297636A1 (en)	2004-06-23	Plasma-assisted melting
AU2003295638A1 (en)	2004-06-18	NOVEL INHIBITORS OF Beta-LACTAMASE
AUPS233702A0 (en)	2002-06-13	Identification of eukaryotic species
AU2003282338A1 (en)	2004-02-25	Determination of protein function
AU2003299025A1 (en)	2004-04-08	Peptides inhibiting specific cleaving activities of presenilins
AU2003217174A1 (en)	2003-07-30	Novel variants of rankl protein
AU2003262141A1 (en)	2003-10-27	Preperation of desloratatine
AU2003304374A1 (en)	2005-02-14	Peptide inhibitors of beta-lactamases
AU2003257541A1 (en)	2004-03-19	Novel crystals
AU2003263738A1 (en)	2003-12-02	Protease inhibitors
AU2003216376A1 (en)	2003-09-09	Enzymes
AU2003282088A1 (en)	2004-06-15	Non-setting protected polyisocyanates
AU2003220607A1 (en)	2003-10-13	Enzymes
AU2003238034A1 (en)	2004-01-23	Novel use of imidazotriazinones
AU2003231074A1 (en)	2003-11-03	Identification of causal factors of variant phenomena

Legal Events

Date	Code	Title	Description
2005-07-21	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase